- Home
- IDYA vs SKE Comparison
IDYA vs SKE Comparison
Compare IDYA & SKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- SKE
- Stock Information
- Founded
- IDYA 2015
- SKE 1979
- Country
- IDYA United States
- SKE Canada
- Employees
- IDYA N/A
- SKE N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- SKE Precious Metals
- Sector
- IDYA Health Care
- SKE Basic Materials
- Exchange
- IDYA Nasdaq
- SKE Nasdaq
- Market Cap
- IDYA 2.3B
- SKE 2.0B
- IPO Year
- IDYA 2019
- SKE N/A
- Fundamental
- Price
- IDYA $24.44
- SKE $18.30
- Analyst Decision
- IDYA Buy
- SKE
- Analyst Count
- IDYA 14
- SKE 0
- Target Price
- IDYA $47.75
- SKE N/A
- AVG Volume (30 Days)
- IDYA 1.2M
- SKE 523.2K
- Earning Date
- IDYA 11-03-2025
- SKE 11-13-2025
- Dividend Yield
- IDYA N/A
- SKE N/A
- EPS Growth
- IDYA N/A
- SKE N/A
- EPS
- IDYA N/A
- SKE N/A
- Revenue
- IDYA $7,000,000.00
- SKE N/A
- Revenue This Year
- IDYA $62.30
- SKE N/A
- Revenue Next Year
- IDYA $285.58
- SKE N/A
- P/E Ratio
- IDYA N/A
- SKE N/A
- Revenue Growth
- IDYA N/A
- SKE N/A
- 52 Week Low
- IDYA $13.45
- SKE $7.32
- 52 Week High
- IDYA $37.19
- SKE $19.33
- Technical
- Relative Strength Index (RSI)
- IDYA 49.04
- SKE 65.80
- Support Level
- IDYA $24.24
- SKE $17.33
- Resistance Level
- IDYA $25.49
- SKE $19.33
- Average True Range (ATR)
- IDYA 1.35
- SKE 0.69
- MACD
- IDYA -0.15
- SKE 0.14
- Stochastic Oscillator
- IDYA 27.13
- SKE 72.39
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About SKE Skeena Resources Limited
Skeena Resources Ltd is a mining company in development stage focusing on the construction and development of the Eskay Creek project in British Columbia. Eskay Creek is the next global gold development project and represents one of the highest-grade and lowest-cost open-pit precious metals mines, with substantial silver by-product production.